Leaflet accompanying the packaging: patient information
Fypalan, 2 mg, coated tablets
Fypalan, 4 mg, coated tablets
Fypalan, 6 mg, coated tablets
Fypalan, 8 mg, coated tablets
Fypalan, 10 mg, coated tablets
Fypalan, 12 mg, coated tablets
Perampanel
You should carefully read the contents of this leaflet before taking this medicine, as it contains important information for you.
- You should keep this leaflet, so that you can read it again if you need to.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Table of contents of the leaflet
- 1. What is Fypalan and what is it used for
- 2. Important information before taking Fypalan
- 3. How to take Fypalan
- 4. Possible side effects
- 5. How to store Fypalan
- 6. Contents of the packaging and other information
1. What is Fypalan and what is it used for
Fypalan contains the active substance perampanel. It belongs to a group of medicines called antiepileptic drugs. These medicines are used to treat epilepsy, where the patient has recurring seizures (epileptic seizures). It has been prescribed for you by your doctor to reduce the number of seizures.
Fypalan is used in combination with other antiepileptic medicines to treat certain types of epilepsy:
- In adults, adolescents (from 12 years of age), and children (from 4 to 11 years of age)
- Fypalan is used to treat seizures that affect only a part of the brain (called partial seizures).
- After such partial seizures, the patient may or may not experience seizures that affect the entire brain (called secondary generalized seizures).
- In adults and adolescents (from 12 years of age) and children (from 7 to 11 years of age)
- Fypalan is also used to treat seizures that affect the entire brain from the start (called primary generalized seizures), which can cause convulsions or loss of consciousness.
2. Important information before taking Fypalan
When not to take Fypalan:
- if you have ever had a severe skin rash, skin peeling, blisters, or ulcers in the mouth after taking perampanel.
- if you are allergic to perampanel or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
If you have liver or kidney problems, or if you have had a history of alcohol or drug abuse, you should discuss this with your doctor or pharmacist before taking Fypalan.
- Fypalan may cause dizziness or drowsiness, especially at the start of treatment.
- Fypalan may increase the risk of falls, especially in elderly patients; this may be due to the patient's condition.
- Fypalan may cause aggression, anger, or violence. It may also cause unusual or extreme changes in behavior and mood, thinking disorders, and loss of contact with reality. If you or your family members or friends notice any of these effects, you should contact your doctor or pharmacist.
In a small number of patients treated with antiepileptic medicines, thoughts of self-harm or suicidal thoughts have occurred. If you experience such thoughts at any time, you should contact your doctor immediately.
- DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) is a condition that can cause flu-like symptoms and a rash, with elevated liver enzymes, eosinophilia, and lymph node enlargement.
- Stevens-Johnson Syndrome (SJS) is a severe skin condition that can cause red, target-like spots or circular patches (often with blisters in the center) on the torso, skin peeling, and ulcers in the mouth, throat, nose, genitals, and eyes. These severe skin conditions can be life-threatening and may lead to death.
If you experience any of these symptoms after taking Fypalan (or if you are unsure), you should contact your doctor or pharmacist.
Children
Fypalan is not recommended for use in children under 4 years of age. The safety and efficacy of Fypalan in children under 4 years of age with partial seizures or under 7 years of age with primary generalized seizures have not been established.
Fypalan and other medicines
You should tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, including those obtained without a prescription and herbal medicines. Taking Fypalan with certain other medicines may cause side effects or affect their efficacy. You should not start or stop taking other medicines without consulting your doctor or pharmacist.
- Other antiepileptic medicines, such as carbamazepine, oxcarbazepine, and phenytoin, used to treat seizures, may affect the efficacy of Fypalan. You should tell your doctor if you are taking or have recently taken these medicines, as dose adjustment may be necessary.
- Felbamate (a medicine used to treat epilepsy) may also affect the efficacy of Fypalan. You should tell your doctor if you are taking or have recently taken this medicine, as dose adjustment may be necessary. Fypalan may affect the efficacy of midazolam (a medicine used to treat prolonged, acute seizures, as a sedative, and for sleep disorders). You should tell your doctor if you are taking midazolam, as dose adjustment may be necessary.
- Certain other medicines, such as rifampicin (a medicine used to treat bacterial infections), St. John's Wort (a medicine used to treat mild anxiety), and ketoconazole (a medicine used to treat fungal infections), may affect the efficacy of Fypalan. You should tell your doctor if you are taking or have recently taken these medicines, as dose adjustment may be necessary.
- Hormonal contraceptives (including oral contraceptives, implants, injections, and patches). You should tell your doctor about any hormonal contraceptives you are taking. Fypalan may reduce the efficacy of certain hormonal contraceptives, such as levonorgestrel. During treatment with Fypalan, you should use other methods of safe and effective contraception (such as condoms or an intrauterine device). You should continue to use these methods for one month after stopping treatment. You should discuss with your doctor which contraceptive method is best for you.
Taking Fypalan with alcohol
You should consult your doctor before consuming alcohol. You should be cautious when consuming alcohol with antiepileptic medicines, including Fypalan.
- Consuming alcohol while taking Fypalan may cause decreased alertness and negatively affect your ability to drive, use machines, or operate equipment.
- Consuming alcohol while taking Fypalan may exacerbate feelings of anger, confusion, or sadness.
Pregnancy and breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a baby, you should ask your doctor for advice before taking this medicine. You should not stop treatment without first discussing it with your doctor.
- Fypalan is not recommended during pregnancy.
- During treatment with Fypalan, you should use effective contraception to avoid becoming pregnant. You should continue to use contraception for one month after stopping treatment. You should tell your doctor if you are using hormonal contraception. Fypalan may reduce the efficacy of certain hormonal contraceptives, such as levonorgestrel. During treatment with Fypalan, you should use other methods of safe and effective contraception (such as condoms or an intrauterine device). You should continue to use these methods for one month after stopping treatment. You should discuss with your doctor which contraceptive method is best for you. It is not known whether the ingredients of Fypalan pass into breast milk. Your doctor will weigh the benefits and risks of taking Fypalan during breastfeeding.
Driving and using machines
You should not drive or operate machinery until you know how Fypalan affects you.
You should discuss with your doctor the impact of epilepsy on your ability to drive or operate machinery.
- Fypalan may cause dizziness or drowsiness, especially at the start of treatment. If you experience these effects, you should not drive, use machines, or operate equipment.
- Consuming alcohol while taking Fypalan may exacerbate these effects.
Fypalan contains lactose
Fypalan contains lactose (a type of sugar). If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking this medicine.
3. How to take Fypalan
You should always take this medicine exactly as your doctor has told you. If you are unsure, you should ask your doctor or pharmacist.
What dose should you take
Treatment of partial and primary generalized seizures in adults and adolescents (12 years of age and older):
The usual starting dose of Fypalan is 2 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 2 mg, up to a maintenance dose between 4 mg and 12 mg, depending on your response to treatment.
- If you have mild or moderate liver problems, the dose should not exceed 8 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
The following table shows the recommended doses for the treatment of partial seizures in children from 4 to 11 years of age and primary generalized seizures in children from 7 to 11 years of age. Further details are provided below in the table.
| Children with body weight: |
30 kg or more | from 20 kg to less than 30 kg | less than 20 kg |
Recommended starting dose | 2 mg/day | 1 mg/day | 1 mg/day |
Recommended maintenance dose | from 4 to 8 mg/day | from 4 to 6 mg/day | from 2 to 4 mg/day |
Recommended maximum dose | 12 mg/day | 8 mg/day | 6 mg/day |
Treatment of partial seizures in children (from 4 to 11 years of age) with a body weight of 30 kg or more:
The usual starting dose of Fypalan is 2 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 2 mg, up to a maintenance dose between 4 mg and 8 mg, depending on your response to treatment. Depending on your individual clinical response and tolerance, the dose may be gradually increased to a maximum dose of 12 mg/day.
- If you have mild or moderate liver problems, the dose should not exceed 4 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
Treatment of partial seizures in children (from 4 to 11 years of age) with a body weight from 20 kg to less than 30 kg:
The usual starting dose of Fypalan is 1 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 1 mg, up to a maintenance dose between 4 mg and 6 mg, depending on your response to treatment. Depending on your individual clinical response and tolerance, the dose may be gradually increased to a maximum dose of 8 mg/day.
- If you have mild or moderate liver problems, the dose should not exceed 4 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
Treatment of partial seizures in children (from 4 to 11 years of age) with a body weight less than 20 kg:
The usual starting dose of Fypalan is 1 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 1 mg, up to a maintenance dose between 2 mg and 4 mg, depending on your response to treatment. Depending on your individual clinical response and tolerance, the dose may be gradually increased to a maximum dose of 6 mg/day.
- If you have mild or moderate liver problems, the dose should not exceed 4 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
Treatment of primary generalized seizures in children (from 7 to 11 years of age) with a body weight of 30 kg or more:
The usual starting dose of Fypalan is 2 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 2 mg, up to a maintenance dose between 4 mg and 8 mg, depending on your response to treatment. Depending on your individual clinical response and tolerance, the dose may be gradually increased to a maximum dose of 12 mg/day.
- If you have mild or moderate liver problems, the dose should not exceed 4 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
Treatment of primary generalized seizures in children (from 7 to 11 years of age) with a body weight from 20 kg to less than 30 kg:
The usual starting dose of Fypalan is 1 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 1 mg, up to a maintenance dose between 4 mg and 6 mg, depending on your response to treatment. Depending on your individual clinical response and tolerance, the dose may be gradually increased to a maximum dose of 8 mg/day.
- If you have mild or moderate liver problems, the dose should not exceed 4 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
Treatment of primary generalized seizures in children (from 7 to 11 years of age) with a body weight less than 20 kg:
The usual starting dose of Fypalan is 1 mg once daily, taken at bedtime.
- Your doctor may gradually increase the dose by 1 mg, up to a maintenance dose between 2 mg and 4 mg, depending on your response to treatment. Depending on your individual clinical response and tolerance, the dose may be gradually increased to a maximum dose of 6 mg/day.
- If you have mild or moderate liver problems, the dose should not exceed 4 mg per day and should not be increased more frequently than every 2 weeks.
- You should not take more Fypalan than your doctor has prescribed. It may take several weeks to determine the correct dose of Fypalan for you.
How to take Fypalan
The tablet should be swallowed whole, with a glass of water. Fypalan can be taken with or without food. The tablets should not be chewed, crushed, or divided.
Taking more Fypalan than prescribed
If you take more Fypalan than prescribed, you should contact your doctor immediately. You may experience confusion, anxiety, aggressive behavior, and decreased level of consciousness.
Missing a dose of Fypalan
- If you miss a dose, you should wait until the next scheduled dose and continue treatment as usual.
- You should not take a double dose to make up for a missed dose.
- If you stop taking Fypalan for less than 7 days, you should continue to take the tablet daily as prescribed by your doctor.
- If you stop taking Fypalan for more than 7 days, you should contact your doctor immediately.
Stopping treatment with Fypalan
You should take Fypalan for as long as your doctor has prescribed. You should not stop treatment unless your doctor decides to. Your doctor may gradually reduce the dose you are taking to prevent seizures from returning or worsening.
4. Possible side effects
Like all medicines, Fypalan can cause side effects, although not everybody gets them.
In a small number of patients treated with antiepileptic medicines, thoughts of self-harm or suicidal thoughts have occurred. If you experience such thoughts at any time, you should contact your doctor immediately.
Very common(affecting more than 1 in 10 people) side effects:
- dizziness
- drowsiness (sleepiness or lethargy)
Common(affecting more than 1 in 100 people) side effects:
- increased or decreased appetite, weight gain
- aggression, anger, irritability, anxiety, or disorientation
- problems with walking or other balance problems (ataxia, gait disturbances, balance disorders)
- slow speech (dysarthria)
- blurred vision or double vision (diplopia)
- peripheral vertigo
- nausea
- back pain
- feeling very tired
- falls
Uncommon(affecting more than 1 in 1,000 people) side effects:
- thoughts of self-harm or suicide, suicide attempts
- hallucinations (seeing, hearing, or feeling things that are not there)
- abnormal thinking and loss of contact with reality (psychotic disorders)
Frequency not known(frequency of side effects cannot be estimated from available data):
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), a condition that can cause flu-like symptoms and a rash, with elevated liver enzymes, eosinophilia, and lymph node enlargement.
- Stevens-Johnson Syndrome (SJS), a severe skin condition that can cause red, target-like spots or circular patches (often with blisters in the center) on the torso, skin peeling, and ulcers in the mouth, throat, nose, genitals, and eyes. These severe skin conditions can be life-threatening and may lead to death.
If you experience any of these symptoms, you should stop taking Fypalan and contact your doctor or seek medical attention immediately. See also section 2.
Reporting side effects
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. You can also report side effects directly to the national reporting system:
Department for Monitoring of Adverse Reactions to Medicinal Products
Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Fypalan
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after "EXP". The expiry date refers to the last day of the month.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. Contents of the packaging and other information
What Fypalan contains
The active substance is perampanel.
Fypalan 2 mg coated tablets
Each coated tablet contains 2 mg of perampanel.
Fypalan 4 mg coated tablets
Each coated tablet contains 4 mg of perampanel.
Fypalan 6 mg coated tablets
Each coated tablet contains 6 mg of perampanel.
Fypalan 8 mg coated tablets
Each coated tablet contains 8 mg of perampanel.
Fypalan 10 mg coated tablets
Each coated tablet contains 10 mg of perampanel.
Fypalan 12 mg coated tablets
Each coated tablet contains 12 mg of perampanel.
The other ingredients are:
Tablet core
Lactose monohydrate, hydroxypropylcellulose, low-substituted, Povidone K30, microcrystalline cellulose, siliconized, magnesium stearate
Coating
2 mg, 6 mg, 8 mg, 10 mg, 12 mg tablets
Partially hydrolyzed polyvinyl alcohol, talc, Macrogol 3350, titanium dioxide (E171)
4 mg tablets
Partially hydrolyzed polyvinyl alcohol, talc, Macrogol 3350
In addition:
2 mg tablet: iron oxide, yellow (E172); iron oxide, red (E172)
4 mg tablet: iron oxide, red (E172)
6 mg tablet: iron oxide, yellow (E172); iron oxide, red (E172)
8 mg tablet: iron oxide, black (E172); iron oxide, red (E172)
10 mg tablet: iron oxide, yellow (E172); iron oxide, black (E172)
12 mg tablet: iron oxide, black (E172); iron oxide, red (E172)
What Fypalan looks like and contents of the pack
Coated tablet
2 mg: yellow, round, biconvex coated tablets
4 mg: red, round, biconvex coated tablets
6 mg: orange, round, biconvex coated tablets
8 mg: pink, round, biconvex coated tablets
10 mg: green, round, biconvex coated tablets
12 mg: gray to purple, round, biconvex coated tablets
Fypalan is available in packs of 7, 10, 28, 30, 98, and 100 coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
G.L. Pharma GmbH
Schlossplatz 1
8502 Lannach
Austria
For further information on this medicine, please contact:
G.L. PHARMA POLAND Sp. z o.o.
Al. Jana Pawła II 61/313
01-031 Warsaw, Poland
Phone: 022/ 636 52 23; 636 53 02
Email: biuro@gl-pharma.pl
Date of last revision of the leaflet: